by Maria Zannes | Nov 8, 2024 | Articles, News
The Alamo City biotech has secured a key win in Japan that could make it a key player in a nearly billion-dollar industry. As published in the San Antonio Business Journal By W. Scott Bailey – Senior Reporter, San Antonio Business Journal BioAffinity Technologies Inc....
by Maria Zannes | Oct 16, 2024 | Articles, News
As published in Mergermarket By Deborah Balshem and Jeff Sheban Summary • Medicare reimbursement providing tailwinds • Expansion into government market imminent • Analyst sees labs chains among potential buyers bioAffinity Technologies [NASDAQ:BIAF], a healthcare...
by Maria Zannes | Oct 13, 2024 | Articles, News
With a San Antonio biotech firm’s test, your phlegm could help save you from cancer. As published by the San Antonio Express-News By Brandon Lingle, Staff Writer The screening method developed by bio Affinity Technologies Inc. uses Al-aided computer analysis...
by Maria Zannes | Oct 11, 2024 | Articles, News
The Alamo City company has gained new commercial access that could greatly expand its reach and its revenue. As published in the San Antonio Business Journal By W. Scott Bailey – Senior Reporter, San Antonio Business Journal BioAffinity Technologies Inc. has reached a...
by Maria Zannes | Jul 3, 2024 | Articles, News
bioAffinity Technologies News Update SAN ANTONIO, Texas (July 3, 2024) – We are pleased to share the latest updates from bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW) as we continue to accelerate the commercialization of CyPath® Lung, our noninvasive diagnostic...
by Maria Zannes | Nov 8, 2023 | Articles, News
The latest move is a key step for an Alamo City company pursuing widespread adoption of its core technology. As published in the San Antonio Business Journal By: W. Scott Bailey – Senior Reporter, San Antonio Business Journal Nov. 6, 2023 San Antonio-based bioAffinity...
